NORDIC CLINIC AS

4070 RANDABERG

Finances

Share Ownership

Return on Equity

−21,91 %

Current Ratio

2,17

Debt-to-Equity Ratio

−4,8

Key figures (NOK)	2022	2021	2020	2019
Revenue	35 678 000	38 296 000	29 735 000	35 638 000
Net Income	1 803 000	4 581 000	−1 246 000	2 929 000
Total Assets	39 253 000	40 678 000	35 384 000	38 786 000
Total Equity	−8 229 000	−8 606 000	−13 806 000	−12 277 000

Income (NOK)	2022	2021	2020	2019
Revenue	35 678 000	38 296 000	29 735 000	35 638 000
Expenditure	33 841 000	34 733 000	30 727 000	32 545 000
Operating Profit	1 838 000	3 563 000	−992 000	3 092 000
Financial Income	987 000	2 253 000	1 670 000	911 000
Financial Costs	1 021 000	1 235 000	1 924 000	1 074 000
Financial Balance	−34 000	1 018 000	−254 000	−163 000
Earnings Before Tax	1 803 000	4 581 000	−1 246 000	2 929 000
Tax	0	0	0	0
Net Income	1 803 000	4 581 000	−1 246 000	2 929 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	21 876 000	22 733 000	22 608 000	22 242 000
Total Current Assets	17 377 000	17 945 000	12 776 000	16 544 000
Total Assets	39 253 000	40 678 000	35 384 000	38 786 000
Total Retained Equity	−11 229 000	−11 606 000	−16 806 000	−15 277 000
Total Equity	−8 229 000	−8 606 000	−13 806 000	−12 277 000
Total Long-Term Debt	39 461 000	40 084 000	39 465 000	38 644 000
Total Current Debt	8 020 000	9 200 000	9 725 000	12 419 000
Total Equity and Debt	39 253 000	40 678 000	35 384 000	38 786 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	35 664 000	37 964 000	29 660 000	28 750 000
Other Income	14 000	332 000	75 000	6 888 000
Revenue	35 678 000	38 296 000	29 735 000	35 638 000
Cost of Goods Sold	6 184 000	5 913 000	4 221 000	3 540 000
Salary Costs	17 705 000	17 151 000	17 944 000	16 335 000
Depreciation	2 070 000	1 832 000	2 120 000	2 034 000
Impairment	0	0	0	0
Expenditure	33 841 000	34 733 000	30 727 000	32 545 000
Operating Profit	1 838 000	3 563 000	−992 000	3 092 000
Financial Income	987 000	2 253 000	1 670 000	911 000
Financial Costs	1 021 000	1 235 000	1 924 000	1 074 000
Financial Balance	−34 000	1 018 000	−254 000	−163 000
Dividends	0	0	0	0
Net Income	1 803 000	4 581 000	−1 246 000	2 929 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	26 000	35 000	78 000	121 000
Real Eastate	14 704 000	15 840 000	16 575 000	17 265 000
Machinery and Plant Facilities	0	0	0	0
Fixtures	6 453 000	6 266 000	5 955 000	4 855 000
Total Tangible Assets	21 158 000	22 106 000	22 530 000	22 120 000
Total Fiancial Fixed Assets	692 000	591 000	0	0
Total Fixed Assets	21 876 000	22 733 000	22 608 000	22 242 000
Stock	2 893 000	4 077 000	2 990 000	1 865 000
Total Investments	0	0	0	0
Cash, Bank	11 425 000	11 803 000	8 935 000	12 405 000
Total Current Assets	17 377 000	17 945 000	12 776 000	16 544 000
Total Assets	39 253 000	40 678 000	35 384 000	38 786 000
Total Equity	−8 229 000	−8 606 000	−13 806 000	−12 277 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	39 461 000	40 084 000	39 465 000	38 644 000
Creditors	287 000	255 000	553 000	552 000
Unpaid Taxes	3 103 000	3 590 000	2 964 000	7 179 000
Dividends	0	0	0	0
Other Current Debt	4 630 000	5 355 000	6 208 000	4 688 000
Total Current Debt	8 020 000	9 200 000	9 725 000	12 419 000
Total Equity and Debt	39 253 000	40 678 000	35 384 000	38 786 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−21,91 %	−53,23 %	9,03 %	−23,86 %
Debt-to-Equity Ratio	−4,8	−4,66	−2,86	−3,15
Operating Profit Margin	5,15 %	9,3 %	−3,34 %	8,68 %
Current Ratio	2,17	1,95	1,31	1,33
Quick Ratio	3,39	3,5	1,9	1,57
Equity Ratio	−0,21	−0,21	−0,39	−0,32
Gross Profit Margin	82,67 %	84,56 %	85,8 %	90,07 %